Executive management

Patrik Eriksson
CEO since January 2024 Born: 1967
Education

MSc in Economics and Business Administration from the Stockholm School of Economics.

Other current assignments

Boston University, School of Dental Medicine, Dean’s advisory board.
Harvard University, Harvard School of Dental Medicine, Dean’s advisory board.
University of Pennsylvania, Penn School of Dental Medicine, Board of Overseers.

Principal work experience

President, Nobel Biocare
President, KaVoKerr
President, Ormco Corporation
President and CEO, Carestream Dental LLC

Shareholding in the company

Subscribed for a total of 81,905 warrants and 4,095 employee stock options under LTI 2023.
Subscribed for 550,000 call options in Vimian at market price from Fidelio Vet Holding AB in December 2023.

Carl-Johan Zetterberg Boudrie
CFO since 2022 Born: 1978
Education

MSc in electrical engineering from the Royal Institute of Technology and MSc in economics from Stockholm University.

Other current assignments

Owner of Calan Consulting AB.

Principal work experience

CEO at Careium AB, CEO and CFO at DORO AB, CFO at Lekolar, Vice President Business Development at Beijer Electronics, and consultant at Capgemini Invent.

Shareholding in the company

4,500 ordinary shares, 0 C shares.
Subscribed for a total of 41,071 warrants in the Company during LTI 2022.

Magnus Kjellberg
CEO of Nextmune since 2017 Born: 1973
Education

MSc in Business and Economics from the Stockholm School of Economics.

Other current assignments

Chairman of the board of a number of subsidiaries within the Group. Board member of a number of subsidiaries within the Group and Nextmune Holding BV, Nextmune BV, Nextmune US LLC, Nextmune AS, Nextmune Scandinavia AB, Nextmune Spain S.L., Nextmune Italy S.r.l., Vetruus Limited and Bova UK Limited.

Principal work experience

VP Corporate Strategy and M&A at Meda.

Shareholding in the company

3,055,001 ordinary shares, 455,972 C shares.
Subscribed for a total of 125,418 warrants in the Company under LTI 2021.

Guy C. Spörri
CEO of Movora since 2020 Born: 1980
Education

MSc in Management, Technology and Economics from ETH Zürich.

Other current assignments

Chairman of the board of KYON AG and Ossium AG. Board member of KYON Pharma (US).

Principal work experience

CEO of Kyon, General Manager of Joint Replacement Division at Stryker and Sales Manager at Johnson & Johnson.

Shareholding in the company

893,376 ordinary shares, 114,831 C shares.
Subscribed for a total of 83,612 warrants in the Company under LTI 2021 and 8,214 warrants under LTI 2022.

Alireza Tajbakhsh
CEO of VetFamily since 2022 Born: 1983
Education

MSc in Economics and Business Administration from the Stockholm School of Economics.

Other current assignments

Chairman of the board and board member of a number of subsidiaries within the Group. Board member of Famano AB, Precis Holding AB (Precis Digital), Seenthis AB and Stiftelsen Vin & Sprithistoriska museet.

Principal work experience

Group CEO of Omnicom Media Group Sweden, COO MTGx and Head of Digital MTG

Chairman of the Board OMD Sweden, Chairman of the Board PHD Sweden, Chairman of the Board Hearts & Science Sweden, Chairman of the Board Drum Sweden. Member of Board Splay Networks & Member of Board Godsmak.se.

Shareholding in the company

292,064 ordinary shares and 125,170 C shares.
Subscribed for a total of 275,000 warrants in the Company under LTI 2022 and 10,000 warrants in the Company under LTI 2023.

Stefano Santarelli
CEO of Indical Bioscience since 2021 Born: 1981
Education

Bachelor of Economics (Honours) at LUISS Guido Carli University in Rome.

Principal work experience

Ontario Teachers’ Pension Plan (OTPP), Bain & Company, Ernst & Young, TIM Telecom Italia, P&G.

Shareholding in the company

0 ordinary shares, 0 C shares.
Subscribed for a total of 82,142 warrants in the Company under LTI 2022 and 81,905 warrants and 4,095 employee stock options under LTI 2023. 

Martin Bengtson
Head of M&A since 2021 Born: 1981
Education

MSc in Finance from the Stockholm School of Economics.

Other current assignments

Board member of HRR Holding AB and Danzinger Gatt Invest AB.

Principal work experience

Head of M&A at Doktor.se, Group M&A Manager at AniCura and Investment Manager at Nordic Capital.

Shareholding in the company

243,950 ordinary shares, 34,850 C shares.
0 warrants.

Maria Dahllöf Tullberg
Head of IR, Communications & Sustainability since 2021 Born: 1981
Education

MSc in Accounting and Financial Management from the Stockholm School of Economics.

Principal work experience

Group Communications Director at AniCura, Head of Marketing & Communications at Moderna Försäkringar and Consultant at JKL Group.

Independent of

7,300 ordinary shares, 0 C shares.
Subscribed for a total of 83,612 warrants in the Company under LTI 2021, 112,689 warrants under LTI 2022 and 80,000 warrants under LTI 2023.

Carl-Johan Ehn
General Counsel since 2022 Born: 1974
Education

Master of laws - LLM from Lund University
Bachelor of Business Administration – Finance from Lund University

Other current assignments

Board member of Elding Oscarson Arkitekter AB
Board member of Tapster AB

Principal work experience

Vice President and Chief Counsel International Operations at Zoetis
Assistant General Counsel at Pfizer
Attorney (Advokat) at Mannheimer Swartling Law Firm

Shareholding in the company

17,000 ordinary shares.
Subscribed for a total of 112,689 warrants in the Company under LTI 2022 and 50,000 warrants in the Company under LTI 2023.

This website uses cookies for analytics and an improved browsing experience. Read more